Berkshire Hathaway (BRK.A) has divested all of its shares in Wells Fargo (WFC), Bristol Myers Squibb (BMY) and AbbVie (ABBV) as of March 31, while picking...
AbbVie (ABBV) said Monday it is working with biotechnology startup Cugene, under which it has agreed to receive the option to license worldwide rights to...
AbbVie (ABBV) said Wednesday its upadacitinib oral therapy for adults with moderate to severe Crohn's disease showed "significantly higher" endoscopic...
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...
| Address | 1 North Waukegan Road North Chicago, Illinois 60064-6400 |
| Phone | +1.847.932.7900 |
| Number of Employees | 30,000 |
| Recent SEC Filing | 05/13/2022 4 |
| Chairman & Chief Executive Officer | Richard A. Gonzalez |
| President & Vice Chairman-Management Board | Michael E. Severino |
| CFO, Vice Chairman-Finance & Commercial Operations | Robert A. Michael |
| Chief Scientific Officer, Senior VP-R&D | Thomas J. Hudson |
| Price Open | $155.38 |
| Previous Close | $155.47 |
| 52 Week Range | $105.56 - 175.91 |
| Market Capitalization | $273.5 B |
| Shares Outstanding | 1.8 B |
| Sector | Health Technology |
| Industry | Pharmaceuticals: Major |
| Current Dividend / Yield | $1.41 / 3.63% |
| Dividend Ex-Date | 04/13/2022 |
| Dividend Pay-Date | 05/16/2022 |
| Dividend Yield 5 Year Average | 4.08% | Next Earnings Announcement | 07/29/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | 22.02 |
| Earnings per Share | $8.17 |
| Beta vs. S&P 500 | N/A |
| Revenue | $32.8 B |
| Net Profit Margin | 21.86% |
| Return on Equity | 85.78% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
